These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 8937535)
21. Lamotrigine: an antiepileptic agent for the treatment of partial seizures. Gilman JT Ann Pharmacother; 1995 Feb; 29(2):144-51. PubMed ID: 7756713 [TBL] [Abstract][Full Text] [Related]
22. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction. Pisani F; Oteri G; Russo MF; Di Perri R; Perucca E; Richens A Epilepsia; 1999 Aug; 40(8):1141-6. PubMed ID: 10448829 [TBL] [Abstract][Full Text] [Related]
23. Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy. Goa KL; Ross SR; Chrisp P Drugs; 1993 Jul; 46(1):152-76. PubMed ID: 7691504 [TBL] [Abstract][Full Text] [Related]
24. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Smith D; Baker G; Davies G; Dewey M; Chadwick DW Epilepsia; 1993; 34(2):312-22. PubMed ID: 8453943 [TBL] [Abstract][Full Text] [Related]
25. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group. Motte J; Trevathan E; Arvidsson JF; Barrera MN; Mullens EL; Manasco P N Engl J Med; 1997 Dec; 337(25):1807-12. PubMed ID: 9400037 [TBL] [Abstract][Full Text] [Related]
26. [The assessment of lamotrigine effectiveness in patients with drug-resistant epilepsy]. Małowidzka-Serwińska M Neurol Neurochir Pol; 1998; 32(2):285-93. PubMed ID: 9760548 [TBL] [Abstract][Full Text] [Related]
27. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Brodie MJ; Richens A; Yuen AW Lancet; 1995 Feb; 345(8948):476-9. PubMed ID: 7710545 [TBL] [Abstract][Full Text] [Related]
28. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy. Sale ME; Natarajan S; Biton V; Vuong A; Hammer AE; Messenheimer JA; Blum D Epilepsy Behav; 2005 Feb; 6(1):63-70. PubMed ID: 15652736 [TBL] [Abstract][Full Text] [Related]
30. Combination vigabatrin and lamotrigine therapy for intractable epilepsy. Schapel GJ; Black AB; Lam EL; Robinson M; Dollman WB Seizure; 1996 Mar; 5(1):51-6. PubMed ID: 8777553 [TBL] [Abstract][Full Text] [Related]
31. Human safety of lamotrigine. Betts T; Goodwin G; Withers RM; Yuen AW Epilepsia; 1991; 32 Suppl 2():S17-21. PubMed ID: 1837776 [TBL] [Abstract][Full Text] [Related]
32. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy. Fitton A; Goa KL Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554 [TBL] [Abstract][Full Text] [Related]
33. Tiagabine: efficacy and safety in adjunctive treatment of partial seizures. Crawford P; Meinardi H; Brown S; Rentmeester TW; Pedersen B; Pedersen PC; Lassen LC Epilepsia; 2001 Apr; 42(4):531-8. PubMed ID: 11440349 [TBL] [Abstract][Full Text] [Related]
34. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy. Otoul C; De Smedt H; Stockis A Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416 [TBL] [Abstract][Full Text] [Related]
35. Overview of the clinical efficacy of lamotrigine. Richens A; Yuen AW Epilepsia; 1991; 32 Suppl 2():S13-6. PubMed ID: 1837775 [TBL] [Abstract][Full Text] [Related]